{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:54:22Z","timestamp":1775339662853,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECINST\/00091\/2018"],"award-info":[{"award-number":["CEECINST\/00091\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011776","name":"Instituto Portugu\u00eas de Oncologia do Porto","doi-asserted-by":"publisher","award":["CI-IPOP-27-2016"],"award-info":[{"award-number":["CI-IPOP-27-2016"]}],"id":[{"id":"10.13039\/501100011776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011776","name":"Instituto Portugu\u00eas de Oncologia do Porto","doi-asserted-by":"publisher","award":["CI-IPOP-92-2018-MCTKidCan"],"award-info":[{"award-number":["CI-IPOP-92-2018-MCTKidCan"]}],"id":[{"id":"10.13039\/501100011776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["CEECIND\/00072\/2018"],"award-info":[{"award-number":["CEECIND\/00072\/2018"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["IF\/00601\/2012"],"award-info":[{"award-number":["IF\/00601\/2012"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["PD\/BDE\/143154\/2019"],"award-info":[{"award-number":["PD\/BDE\/143154\/2019"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["RNCCCP.CCC-CI-IPOP-LAB3-NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["RNCCCP.CCC-CI-IPOP-LAB3-NORTE-01-0145-FEDER-072678"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["SFRH\/BD\/136007\/2018"],"award-info":[{"award-number":["SFRH\/BD\/136007\/2018"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008308","name":"Comprehensive Cancer Center, City of Hope","doi-asserted-by":"publisher","award":["SFRH\/BD\/92786\/2013"],"award-info":[{"award-number":["SFRH\/BD\/92786\/2013"]}],"id":[{"id":"10.13039\/100008308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005111","name":"BMC Software","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.trsl.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T04:32:49Z","timestamp":1654921969000},"page":"110-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Epigenetically-regulated miR-30a\/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness"],"prefix":"10.1016","volume":"249","author":[{"given":"GON\u00c7ALO","family":"OUTEIRO-PINHO","sequence":"first","affiliation":[]},{"given":"DANIELA","family":"BARROS-SILVA","sequence":"additional","affiliation":[]},{"given":"FILIPA","family":"MOREIRA-SILVA","sequence":"additional","affiliation":[]},{"given":"JO\u00c3O","family":"LOBO","sequence":"additional","affiliation":[]},{"given":"ISA","family":"CARNEIRO","sequence":"additional","affiliation":[]},{"given":"ANT\u00d3NIO","family":"MORAIS","sequence":"additional","affiliation":[]},{"given":"EDUARDA P.","family":"MARTINS","sequence":"additional","affiliation":[]},{"given":"C\u00c9LINE S.","family":"GON\u00c7ALVES","sequence":"additional","affiliation":[]},{"given":"BRUNO M.","family":"COSTA","sequence":"additional","affiliation":[]},{"given":"MARGARETA P.","family":"CORREIA","sequence":"additional","affiliation":[]},{"given":"RUI","family":"HENRIQUE","sequence":"additional","affiliation":[]},{"given":"CARMEN","family":"JER\u00d3NIMO","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.06.009_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.trsl.2022.06.009_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2012.06.003","article-title":"Genomics and epigenomics of renal cell carcinoma","volume":"23","author":"Maher","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2022.06.009_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.009_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMra1601333","article-title":"Systemic therapy for metastatic renal-cell carcinoma","volume":"376","author":"Choueiri","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2022.06.009_bib0007","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of urology guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0008","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/cancers12082214","article-title":"Renal cell tumors: uncovering the biomarker potential of ncRNAs","volume":"12","author":"Outeiro-Pinho","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.trsl.2022.06.009_bib0009","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2022.06.009_bib0010","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/onc.2009.493","article-title":"Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma","volume":"29","author":"Morris","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2022.06.009_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2012.01.022","article-title":"Rap1GAP regulates renal cell carcinoma invasion","volume":"320","author":"Kim","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2022.06.009_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2016.01.032","article-title":"miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma","volume":"374","author":"Xiao","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2022.06.009_bib0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0014","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.trsl.2022.06.009_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/cc.8.3.7526","article-title":"How epigenetics can explain human metastasis: a new role for microRNAs","volume":"8","author":"Lujambio","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2022.06.009_bib0016","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2022.06.009_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4419-9967-2_6","article-title":"Epigenetic regulation of miRNAs in cancer","volume":"754","author":"Fabbri","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2013.05.061","article-title":"Epigenetic regulation of microRNA expression in renal cell carcinoma","volume":"436","author":"Schiffgen","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2022.06.009_bib0019","first-page":"10595","article-title":"Demethylation of miR-10b plays a suppressive role in ccRCC cells","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9623412","article-title":"miR-30 family: a promising regulator in development and disease","volume":"2018","author":"Mao","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trsl.2022.06.009_bib0021","doi-asserted-by":"crossref","first-page":"e67294","DOI":"10.1371\/journal.pone.0067294","article-title":"Down-regulated miR-30a in clear cell renal cell carcinoma correlated with tumor hematogenous metastasis by targeting angiogenesis-specific DLL4","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2022.06.009_bib0022","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cas.12291","article-title":"Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma","volume":"104","author":"Huang","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.trsl.2022.06.009_bib0023","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-020-01600-3","article-title":"MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples","volume":"39","author":"Outeiro-Pinho","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.trsl.2022.06.009_bib0024","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2022.06.009_bib0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0026","doi-asserted-by":"crossref","first-page":"e2859","DOI":"10.1038\/cddis.2017.252","article-title":"The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.06.009_bib0027","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/cancers12051066","article-title":"Sirtuins\u2019 deregulation in bladder cancer: SIRT7 is implicated in tumor progression through epithelial to mesenchymal transition promotion","volume":"12","author":"Monteiro-Reis","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.trsl.2022.06.009_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41419-017-0241-y","article-title":"MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis","volume":"9","author":"Barros-Silva","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.06.009_bib0029","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3390\/cancers11101535","article-title":"Detailed characterization of immune cell infiltrate and expression of immune checkpoint molecules PD-L1\/CTLA-4 and MMR proteins in testicular germ cell tumors disclose novel disease biomarkers","volume":"11","author":"Lobo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.trsl.2022.06.009_bib0030","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.18632\/aging.102226","article-title":"lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p\/SOX9 axis","volume":"11","author":"Zhou","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.trsl.2022.06.009_bib0031","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.emboj.7601019","article-title":"Mammalian twinfilin sequesters ADP-G-actin and caps filament barbed ends: implications in motility","volume":"25","author":"Helfer","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.trsl.2022.06.009_bib0032","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10549-012-2346-4","article-title":"MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion","volume":"137","author":"Bockhorn","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.trsl.2022.06.009_bib0033","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4161\/cbt.6.8.4486","article-title":"DNA methylation regulates MicroRNA expression","volume":"6","author":"Han","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.trsl.2022.06.009_bib0034","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2011.354","article-title":"DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer","volume":"31","author":"Lopez-Serra","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2022.06.009_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-017-0604-0","article-title":"MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b\/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors","volume":"16","author":"Torres-Ferreira","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2022.06.009_bib0036","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13148-018-0475-2","article-title":"A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97","volume":"10","author":"Ramalho-Carvalho","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.trsl.2022.06.009_bib0037","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-017-0415-1","article-title":"Downregulation of miR-130b\u223c301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer","volume":"10","author":"Ramalho-Carvalho","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0038","doi-asserted-by":"crossref","first-page":"31852","DOI":"10.1038\/srep31852","article-title":"Epithelial-mesenchymal transition-associated microRNA\/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma","volume":"6","author":"Mlcochova","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2022.06.009_bib0039","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1245\/s10434-013-3361-3","article-title":"MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases","volume":"21","author":"Heinzelmann","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-2.14632","article-title":"Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma","volume":"42","author":"Onyshchenko","year":"2020","journal-title":"Exp Oncol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0041","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1159\/000460618","article-title":"A feedback loop between miR-30a\/c-5p and DNMT1 mediates cisplatin resistance in ovarian cancer cells","volume":"41","author":"Han","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trsl.2022.06.009_bib0042","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1245\/s10434-019-07578-3","article-title":"4-miRNA score predicts the individual metastatic risk of renal cell carcinoma patients","volume":"26","author":"Heinzelmann","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0043","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bfgp\/elz002","article-title":"Interplay between miRNAs and host genes and their role in cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.trsl.2022.06.009_bib0044","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","article-title":"CRISPR technologies for precise epigenome editing","volume":"23","author":"Nakamura","year":"2021","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0045","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1159\/000484394","article-title":"MicroRNA-30a-5p inhibits the growth of renal cell carcinoma by modulating GRP78 expression","volume":"43","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trsl.2022.06.009_bib0046","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1111\/jcmm.14553","article-title":"Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5","volume":"23","author":"Song","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2022.06.009_bib0047","first-page":"406","article-title":"miR-30a regulates the proliferation and invasion of breast cancer cells by targeting Snail","volume":"17","author":"Xiao","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2022.06.009_bib0048","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/ijms18081826","article-title":"MiR-30a-5p inhibits epithelial-to-mesenchymal transition and upregulates expression of tight junction protein claudin-5 in human upper tract urothelial carcinoma cells","volume":"18","author":"Chung","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.06.009_bib0049","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopha.2017.06.084","article-title":"MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1","volume":"93","author":"Cao","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2022.06.009_bib0050","first-page":"3038","article-title":"MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9","volume":"16","author":"Jiang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2022.06.009_bib0051","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/1078-0432.CCR-16-0943","article-title":"miR-206 inhibits stemness and metastasis of breast cancer by targeting MKL1\/IL11 pathway","volume":"23","author":"Samaeekia","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2022.06.009_bib0052","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.18632\/aging.102307","article-title":"Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1","volume":"11","author":"Hua","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.trsl.2022.06.009_bib0053","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/ncomms2393","article-title":"MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11","volume":"4","author":"Bockhorn","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.06.009_bib0054","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.3748\/wjg.v25.i42.6311","article-title":"MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis","volume":"25","author":"Sun","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2022.06.009_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.lfs.2018.10.067","article-title":"Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma","volume":"215","author":"Kaishang","year":"2018","journal-title":"Life Sci"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:46:07Z","timestamp":1761828367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":55,"alternative-id":["S1931524422001414"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.06.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetically-regulated miR-30a\/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}